Jeffrey S. Mandak

Modifiable Risk Factors for Vascular Access Site Complications in the IMPACT II Trial of Angioplasty With Versus Without Eptifibatide

Jeffrey S. Mandak, James C. Blankenship, Laura H. Gardner et al. · Journal of the American College of Cardiology · 1998 · 82 citations

Thrombosis, Versus Without Eptifibatide, Cardiovascular Disease +14

Exercise Training for Heart Failure Patients Improves Respiratory Muscle Endurance, Exercise Tolerance, Breathlessness, and Quality of Life

Timothy R. McConnell, Jeffrey S. Mandak, Jeffrey S. Sykes et al. · Journal of Cardiopulmonary Rehabilitation · 2003 · 56 citations

Echocardiography in the evaluation of cardiac pheochromocytoma

Jeffrey S. Mandak, Charles Benoit, Ralph H. Starkey et al. · American Heart Journal · 1996 · 26 citations

Heart Failure, Cardiovascular Disease, Cardiac Pheochromocytoma +6

Angle closure glaucoma complicating systemic atropine use in the cardiac catheterization laboratory

Jeffrey S. Mandak, Pierre Minerva, Thomas W. Wilson et al. · Catheterization and Cardiovascular Diagnosis · 1996 · 14 citations